Evidence map›Paper›PMID 39184920›Full record

ArticleDermatology research and practice2024

Molecular Signature of miR-34a/NEAT-1/p53 Axis in Mycosis Fungoides.

Reham Fares, Shimaa M Elasmer, Abeer Khalefa A, Olfat G Shaker, Samar M El-Tahlawi, Ahmed Sabri, Sara M Yaseen

Abstract read
In one paragraph

Article in Dermatology research and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Reham FaresDepartment of Medical Biochemistry and Molecular Biology Faculty of Medicine Fayoum University, Fayoum, Egypt.ORCID https://orcid.org/0000-0002-3737-9187
Shimaa M ElasmerDepartment of Clinical and Chemical Pathology Faculty of Medicine Fayoum University, Fayoum, Egypt.ORCID https://orcid.org/0000-0002-6311-8116
Abeer Khalefa ADepartment of Physiology Faculty of Medicine Zagazig University, Zagazig, Egypt.ORCID https://orcid.org/0000-0001-7757-0771
Olfat G ShakerDepartment of Medical Biochemistry and Molecular Biology Faculty of Medicine Cairo University, Cairo, Egypt.ORCID https://orcid.org/0000-0002-3031-3599
Samar M El-TahlawiDepartment of Dermatology Faculty of Medicine Cairo University, Cairo, Egypt.ORCID https://orcid.org/0000-0002-7897-0117
Ahmed SabriFayoum General Hospital, Fayoum, Egypt.ORCID https://orcid.org/0009-0000-4336-9631
Sara M YaseenDepartment of Dermatology, STDs & Andrology Faculty of Medicine Fayoum University, Fayoum, Egypt.ORCID https://orcid.org/0000-0002-1240-6820

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mycosis fungoides (MF) is a type of cutaneous T-cell lymphoma where red rash exists on the skin. Understanding the role of miRNAs and ncRNAs in p53-response has become an open discussion, as they can regulate p53 or its downstream targets, and ncRNAs themselves. Objectives: To evaluate the serum levels of NEAT-1, miR-34a, and p53 in MF patients and its relation to healthy controls to indicate whether it has a potential role in the pathogenesis of the disease. Results: There were significant elevations in the expression levels of both NEAT-1 (5.10 ± 1.16) and p53 (277.28 ± 62.02) in the serum of MF patients in comparison with controls (1.01 ± 0.031) and (194.29 ± 16.039), respectively, while the level of miR-34a tends to decrease in MF patients (0.24 ± 0.15). There are no significant difference between MF stages and the level of miR-34a, while in NEAT-1 and p53, there are significant differences with Conclusion: The combination of miR-34a, NEAT-1, and p53 may be considered as potential biomarkers that play an active role in the disease process of MF for helping in its early diagnosis and stage identification as well.

Identifiers

PMID39184920
PMCPMC11343631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.